- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neuroendocrine Tumor Gastrointestinal, Hormone-Secreting in New Zealand
Total 1318 results
-
InxMed (Shanghai) Co., Ltd.RecruitingMetastatic MelanomaUnited States, Australia
-
Anthony Joshua, FRACPSt Vincent's Hospital, SydneyActive, not recruiting
-
Esanex Inc.Completed
-
Yale UniversityCompleted
-
Bristol-Myers SquibbCompleted
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCActive, not recruitingMelanoma Stage IIIAustralia
-
Immunocore LtdCompletedMalignant MelanomaUnited Kingdom, United States
-
Duke UniversityNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
PfizerTerminatedMelanoma | Breast Neoplasms | Colonic NeoplasmsUnited States
-
National Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Rhabdoid Tumor | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Rhabdoid Tumor | Refractory Rhabdoid Tumor | Epithelioid Sarcoma | Kidney Medullary Carcinoma | Atypical Teratoid/Rhabdoid Tumor | Poorly Differentiated Chordoma | Recurrent Atypical... and other conditionsUnited States, Australia, Canada
-
Bristol-Myers SquibbCompleted
-
Medivation, Inc.CompletedMelanoma | Malignant MelanomaUnited States, Israel
-
Bristol-Myers SquibbCompleted
-
CuraGen CorporationCompletedUnresectable Stage III or Stage IV MelanomaUnited States
-
University of SydneyMelanoma and Skin Cancer Trials LimitedCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownMelanoma (Skin)United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
New Mexico Cancer Care AllianceTerminatedMelanomaUnited States
-
New Mexico Cancer Care AllianceTerminated
-
Georgetown UniversityExelixis; Hackensack Meridian Health; MedStar Franklin Square Medical CenterSuspendedMelanomaUnited States
-
MorphotekTerminatedMelanoma | Metastatic Melanoma | Advanced Melanoma | Malignant Metastatic MelanomaUnited States
-
Novartis PharmaceuticalsCompletedBRAF-positive Metastatic MelanomaUnited States
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
National Cancer Institute (NCI)CompletedSorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgeryStage IV Melanoma | Stage III MelanomaUnited States
-
PfizerTerminatedGastrointestinal Stromal TumorUnited States, Korea, Republic of, Spain, United Kingdom, Italy, Germany, Hong Kong
-
GlaxoSmithKlineCompletedMelanomaFrance, Italy, Germany, Netherlands, Switzerland, United Kingdom, Austria, Australia
-
Eisai Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | Carcinoma, Hepatocellular | Colorectal NeoplasmsSpain, United States, United Kingdom, Japan, France
-
GlaxoSmithKlineCompletedMelanomaAustralia, United States
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingNon-Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Any Solid TumorUnited States, Japan, Taiwan, Australia, Korea, Republic of, Israel, Spain, Switzerland, Singapore, France, Canada, Italy, Germany, United Kingdom, Hong Kong, Denmark
-
Fate TherapeuticsCompletedMelanoma | Lymphoma | Renal Cell Carcinoma | Cervical Cancer | Head and Neck Cancer | Small Cell Lung Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumors | HER2-positive Breast Cancer | Pancreas Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedGastrointestinal Stromal TumorUnited States, Canada
-
Immunocore LtdAstraZenecaCompletedMalignant MelanomaUnited States
-
Immunocore LtdTerminated
-
GlaxoSmithKlineCompleted
-
Yana NajjarMerck Sharp & Dohme LLCCompletedMelanomaUnited States
-
NewLink Genetics CorporationTerminated
-
Mateon TherapeuticsCompletedNeuroendocrine TumorsUnited States
-
Novartis PharmaceuticalsCompletedBRAF v600 Mutated Metastatic MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
National Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Melanoma and Skin Cancer Trials LimitedTrans Tasman Radiation Oncology GroupActive, not recruiting